Pediatric glioblastoma in the setting of constitutional mismatch-repair deficiency treated with upfront lomustine and nivolumab
- PMID: 37881859
- DOI: 10.1002/pbc.30757
Pediatric glioblastoma in the setting of constitutional mismatch-repair deficiency treated with upfront lomustine and nivolumab
References
REFERENCES
-
- Arora RS, Alston RD, Eden TOB, et al. Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England. Neuro Oncol. 2009;11(4):403-413.
-
- Larkin T, Das A, Bianchi V, et al. Upfront adjuvant immunotherapy of replication repair-deficient pediatric glioblastoma with chemoradiation-sparing approach. JCO Precis Oncol. 2021;5:1426-1431.
-
- Partap S, Monje M. Pediatric brain tumors. Continuum (Minneap Minn). 2020;26(6):1553-1583.
-
- Guerrini-Rousseau L, Varlet P, Colas C, et al. Constitutional mismatch-repair deficiency-associated brain tumors: report from the European C4CMMRD consortium. Neurooncol Adv. 2019;1(1):vdz033.
-
- Suerink M, Ripperger T, Messiaen L, et al. Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy. J Med Genet. 2019;56(2):53-62.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical